ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 109 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7 | +40.0% | 14,110 | +54.6% | 0.00% | – |
| Q1 2023 | $5 | -83.9% | 9,128 | -81.0% | 0.00% | – |
| Q4 2022 | $31 | -99.9% | 47,932 | +180.5% | 0.00% | – |
| Q3 2022 | $29,000 | +16.0% | 17,090 | -17.5% | 0.00% | – |
| Q2 2022 | $25,000 | -47.9% | 20,724 | -72.3% | 0.00% | – |
| Q1 2022 | $48,000 | +37.1% | 74,692 | +129.3% | 0.00% | – |
| Q4 2021 | $35,000 | -85.6% | 32,571 | -63.5% | 0.00% | – |
| Q3 2021 | $243,000 | +3.4% | 89,317 | 0.0% | 0.00% | – |
| Q2 2021 | $235,000 | -21.4% | 89,317 | +7.3% | 0.00% | -100.0% |
| Q1 2021 | $299,000 | +190.3% | 83,228 | +102.3% | 0.00% | – |
| Q4 2020 | $103,000 | -9.6% | 41,138 | -9.5% | 0.00% | – |
| Q3 2020 | $114,000 | -55.6% | 45,459 | -42.1% | 0.00% | – |
| Q2 2020 | $257,000 | +127.4% | 78,446 | +69.5% | 0.00% | – |
| Q1 2020 | $113,000 | -39.2% | 46,292 | +16.9% | 0.00% | – |
| Q4 2019 | $186,000 | +365.0% | 39,596 | +323.5% | 0.00% | – |
| Q3 2019 | $40,000 | -86.5% | 9,349 | -81.6% | 0.00% | -100.0% |
| Q2 2019 | $296,000 | +88.5% | 50,810 | +24.5% | 0.00% | – |
| Q1 2019 | $157,000 | +141.5% | 40,814 | +17.2% | 0.00% | – |
| Q4 2018 | $65,000 | -68.0% | 34,819 | -45.3% | 0.00% | -100.0% |
| Q3 2018 | $203,000 | +4.6% | 63,685 | -1.0% | 0.00% | 0.0% |
| Q2 2018 | $194,000 | -43.1% | 64,335 | -26.2% | 0.00% | -93.3% |
| Q1 2018 | $341,000 | +244.4% | 87,230 | +261.6% | 0.02% | +275.0% |
| Q4 2017 | $99,000 | -48.7% | 24,122 | -23.6% | 0.00% | -50.0% |
| Q3 2017 | $193,000 | +77.1% | 31,572 | +82.0% | 0.01% | +60.0% |
| Q1 2017 | $109,000 | -32.3% | 17,344 | -42.4% | 0.01% | -50.0% |
| Q4 2016 | $161,000 | +94.0% | 30,094 | +103.7% | 0.01% | +66.7% |
| Q3 2016 | $83,000 | -70.1% | 14,774 | -70.9% | 0.01% | -68.4% |
| Q2 2016 | $278,000 | +146.0% | 50,713 | +230.2% | 0.02% | +111.1% |
| Q1 2016 | $113,000 | -74.8% | 15,360 | -71.6% | 0.01% | -74.3% |
| Q4 2015 | $449,000 | +40.3% | 54,068 | +52.1% | 0.04% | +52.2% |
| Q3 2015 | $320,000 | +370.6% | 35,558 | +523.1% | 0.02% | +283.3% |
| Q2 2015 | $68,000 | – | 5,707 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |